The 20 Best Glucagonoma Doctors in Maryland, US

Jin He, M.D., Ph.D., is a professor of surgery at the Johns Hopkins University School of Medicine and is the Division Chief of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology. Dr. He specializes in diseases and tumors of the pancreas, liver, bile duct, and gallbladder. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure. Dr. He received his medical degree from Beijing Medical University and a Ph.D. in oncology from Fudan University Shanghai Medical College. He completed the Halsted general surgery residency training at Johns Hopkins, followed by an ACGME accredited fellowship in complex general surgical oncology at Johns Hopkins. Dr. He is the John Cameron Professor of Alimentary Tract Diseases. Dr. He’s research focuses on personalized treatment through stratifying pancreatic tumors on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published extensively in peer-reviewed journals and lectured internationally. He serves on several national committees, including the NCCN panel on neuroendocrine tumors and the Alliance for Clinical Trials in Oncology. Dr. He is rated as an Advanced provider by MediFind in the treatment of Glucagonoma. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Pancreaticoduodenectomy.

Ana De Jesus is an Oncologist in Baltimore, Maryland. Dr. De Jesus is rated as an Advanced provider by MediFind in the treatment of Glucagonoma. Her top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Cameron has had a long and distinguished career in alimentary tract diseases and specifically in pancreatic cancer. He has won worldwide acclaim for mastering the Whipple procedure. At the beginning of his career, the mortality rate from the Whipple procedure was nearly 30 percent. He has worked to lower that to 1 percent to 2 percent at Johns Hopkins. He has operated on more patients with pancreatic cancer and done more Whipple resections than any other surgeon in the world. In addition to maintaining a busy practice that focuses mainly on pancreatic surgery, he has been a leader in the surgical profession, serving as president of the American College of Surgeons, Society for Surgery of the Alimentary Tract, Southern Surgical Association, Society of Clinical Surgery, Society of Surgical Chairmen, Halsted Society and American Surgical Association. He served as chief of surgery for The Johns Hopkins Hospital for nineteen years. Dr. Cameron obtained his undergraduate degree from Harvard University in 1958, and his medical degree from The Johns Hopkins University School of Medicine in 1962. All of his training in General and Thoracic Surgery was obtained at The Johns Hopkins Hospital. Dr. Cameron is rated as an Experienced provider by MediFind in the treatment of Glucagonoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Ampullary Cancer, Pancreatectomy, and Small Bowel Resection.

Dung Le, M.D. is a professor of oncology at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer Center. Her research interests include novel approaches to patients with gastrointestinal malignancies. She has served as the principal investigator (PI) on many clinical trials focused on testing immunotherapy in patients with gastrointestinal malignancies and she has also served as the national PI on several studies including: anti-programmed death-1 (PD-1) in tumors with mismatch repair deficiency; a clinical trial in advanced pancreatic cancer patients evaluating the safety, tolerability and immune response to CRS-207, a listeria vaccine platform which has been modified to express the tumor antigen mesothelin; a multi-center, phase 2 study testing CRS-207 as a boost to allogenic pancreatic tumor cells transfected with GM-CSF gene (GVAX) for treatment of advanced pancreatic adenocarcinoma (PDA); a trial testing GVAX/ipilimumab in the maintenance setting for metastatic pancreatic cancer; and GVAX/CRS-207 +/- nivolumab in metastatic pancreatic cancer. These studies incorporate extensive laboratory correlates and have involved collaborations with clinicians and bench scientists with expertise in the fields of immunotherapy and cancer genomics. Dr. Le is rated as an Experienced provider by MediFind in the treatment of Glucagonoma. Her top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Gastroesophageal Junction Cancer, and Familial Pancreatic Cancer.

Dr. Cunningham earned his M.D. from George Washington University and completed general surgery residency at the University of Maryland. He has completed fellowships in both oncology research and pancreatic and hepatobiliary surgery at Johns Hopkins Hospital. Throughout his career, he has been a prolific contributor and editor with over 100 contributions to a variety of medical journals, guidelines, conferences and textbooks [see Research tab]. He has also served as a Cancer Liaison Physician for the American College of Surgeons, Commission on Cancer. A member the American College of Surgeons, the Society for American Gastrointestinal & Endoscopic Surgeons, the Americas Hepato-Pancreato-Biliary Association, the International Hepato-Pancreato-Biliary Association, the Society for Surgical Oncology, the Society for Surgery of the Alimentary Tract, and the Pancreas Club, Dr. Cunningham offers world-class multidisciplinary and minimally invasive evaluation and treatment of pancreatic, biliary and liver diseases, both benign and malignant. LinkedIn https://www.linkedin.com/in/stevenccunningham. Dr. Cunningham is rated as an Experienced provider by MediFind in the treatment of Glucagonoma. His top areas of expertise are Biliary Dyskinesia, Gallbladder Disease, Pancreatic Cancer, Gallbladder Removal, and Pancreaticoduodenectomy.

Dr. Daniel Laheru is a cancer specialist in Baltimore, caring for patients with pancreatic cancer, colorectal cancer and neuroendocrine cancers. Dr. Laheru serves as co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care at Johns Hopkins Medicine. Dr. Laheru received his undergraduate degree in chemistry from The University of Utah. He earned his M.D. at Baylor College of Medicine. He completed his residency at The University of Utah Hospital and Clinics and performed a fellowship in medical oncology at The Johns Hopkins University School of Medicine and The Johns Hopkins Oncology Center. Dr. Laheru joined the Johns Hopkins faculty in 2001. Dr. Laheru's research interests include pancreatic cancer and chemotherapy resistance in pancreatic cancer. With Elizabeth Jaffee, M.D., he developed a vaccine that supercharges the immune system and causes immune cells, which tend to be tolerant of cancer, to seek out and kill pancreatic cancer cells throughout the body. He has given numerous invited talks on pancreatic cancer and other cancers both nationally and internationally. He has authored over 200 papers focused on pancreatic cancer. Dr. Laheru serves as associate editor of Annals of Pancreatic Cancer. He has been recognized by the American Society of Clinical Oncology with the Young Investigator Award, by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Isaac and Catharine Hecht Scholar and has been elected to the Miller-Coulson Academy of Clinical Excellence. He is a member of the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Laheru is rated as an Experienced provider by MediFind in the treatment of Glucagonoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Loc Le is a Gastroenterologist in Baltimore, Maryland. Dr. Le is rated as an Experienced provider by MediFind in the treatment of Glucagonoma. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome (IBS), Barrett Esophagus, Colonoscopy, and Endoscopy.

Richard Burkhart, M.D., is an Associate Professor of Surgery at The Johns Hopkins Hospital with a focus on complex minimally-invasive surgery and research for cancers of the pancreas, liver and bile ducts. Dr. Burkhart received his medical degree from Boston University and completed his surgical residency and research fellowships at the Thomas Jefferson University Hospital in Philadelphia and the Cold Spring Harbor Laboratories. He is a member of several professional organizations, including the American Association of Cancer Research, the American College of Surgeons, the Society of Surgery for the Alimentary Tract, the Pancreas Club, and the Society of Surgical Oncology. Outside the operating room, Dr. Burkhart heads a multidisciplinary laboratory team dedicated to bringing next-generation precision medicine approaches into the routine clinical care of patients that we serve. He has a particular research interest in using personalized models of pancreas cancer, made from tumor during and immediately after surgical resection, to select the best chemotherapy for each patient to support long-term survival and improve rates of disease cure. The laboratory team, funded in part by the National Institutes of Health, the National Cancer Institute, the Lustgarten Foundation and Stand Up to Cancer, is also thankful to the many patients who have supported the work through philanthropic gift. Dr. Burkhart is rated as an Experienced provider by MediFind in the treatment of Glucagonoma. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.

Dr. Shin specializes Barrett's esophagus, pancreatobiliary disease (pancreatic cyst, family history of pancreatic cancer), GI malignancy, and advanced endoscopy, including endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS). Dr. Shin is rated as an Experienced provider by MediFind in the treatment of Glucagonoma. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Bile Duct Stricture, Endoscopy, and Pancreaticoduodenectomy.

Syed Mahmood is a Hematologist and a Hematologist Oncology provider in Rockville, Maryland. Dr. Mahmood is rated as an Experienced provider by MediFind in the treatment of Glucagonoma. His top areas of expertise are Thrombocytopenia, RUNX1 Familial Platelet Disorder, Lynch Syndrome, and Colorectal Cancer.

Najeff Waseem is a Hematologist and a Hematologist Oncology provider in Columbia, Maryland. Dr. Waseem is rated as an Experienced provider by MediFind in the treatment of Glucagonoma. His top areas of expertise are Thrombocytopenia, Agranulocytosis, Chronic Familial Neutropenia, and Triple-Negative Breast Cancer.

John Wallmark is a Hematologist Oncology provider in Rockville, Maryland. Dr. Wallmark is rated as an Experienced provider by MediFind in the treatment of Glucagonoma. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Multiple Myeloma, and Colorectal Cancer.

Kasra Adham is a Gastroenterologist in Temple Hills, Maryland. Dr. Adham is rated as an Experienced provider by MediFind in the treatment of Glucagonoma. His top areas of expertise are Gastrointestinal Bleeding, Chronic Idiopathic Constipation (CIC), Pancreatic Cancer, Endoscopy, and Gastrectomy.

Kanan Hudhud is an Oncologist in Mount Airy, Maryland. Dr. Hudhud is rated as an Advanced provider by MediFind in the treatment of Glucagonoma. His top areas of expertise are Pancreatic Islet Cell Tumor, Metastatic Insulinoma, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia.

Andrew Mowery is a Gastroenterologist in Frederick, Maryland. Dr. Mowery is rated as an Advanced provider by MediFind in the treatment of Glucagonoma. His top areas of expertise are Gastritis, Chronic Erosive Gastritis, Childhood Volvulus, Colonoscopy, and Gastrectomy.

Dawei Yang is a Gastroenterologist in Frederick, Maryland. Dr. Yang is rated as an Advanced provider by MediFind in the treatment of Glucagonoma. His top areas of expertise are Diverticular Disease, Indigestion, Familial Adenomatous Polyposis, Gastrectomy, and Colonoscopy.

Sandy Kotiah is a Hematologist in Baltimore, Maryland. Dr. Kotiah is rated as an Advanced provider by MediFind in the treatment of Glucagonoma. Her top areas of expertise are Neuroendocrine Tumor, Paget Disease of the Breast, Anemia, Lynch Syndrome, and Bone Marrow Aspiration.

Nouman Asif is an Oncologist in Frederick, Maryland. Dr. Asif is rated as an Advanced provider by MediFind in the treatment of Glucagonoma. His top areas of expertise are Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Anemia, and Thrombocytopenia.

Sadaf Taimur is an Oncologist in Frederick, Maryland. Dr. Taimur is rated as an Advanced provider by MediFind in the treatment of Glucagonoma. Her top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Paget Disease of the Breast, and Pulmonary Embolism.

Amr-zakaria Hegazi is a Hematologist in Frederick, Maryland. Dr. Hegazi is rated as an Advanced provider by MediFind in the treatment of Glucagonoma. His top areas of expertise are Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Anemia, Pulmonary Embolism, and Bone Marrow Aspiration.